adult: Research & Clinical Takeaways

Age-specific evidence for adult — concise summaries and practical next steps.

Papers

Evaluating the Efficacy of Soothing Agents in Mitigating 0.1% Retinol‐Induced Skin Irritation: A Patch Test

Journal of Cosmetic Dermatologyn=21
💡

When selecting retinol products for sensitive skin, co‑formulations with 2% PLG, 5% ceramides, 3% acetyl glucosamine, 2% panthenol, 0.2% TECA, or...

Clinical insight

Allogeneic haematopoietic cell transplant in cutaneous T‐cell lymphomas: Recommendations from the <scp>EBMT PH</scp>&amp;G Committee

Journal of the European Academy of Dermatology and Venereology
💡

Refer high‑risk MF/SS early; aim for CR or deep response (VGPR or mSWAT <10) before RIC allo‑HCT, prefer MRD/MUD donors, and observe a 6‑week washout...

Clinical insight

Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaftn=14
💡

Combining BV with RTx (sequentially or concurrently) was feasible and generally well tolerated, with expected toxicities and no new safety signals....

Clinical insight

Monoclonal Cryoglobulinemia Clinically Mimicking Leukocytoclastic Vasculitis: A Case Report and Literature Review

The American Journal of Dermatopathologyn=1
💡

In vasculitic-appearing eruptions, consider monoclonal cryoglobulinemia and assess for an underlying B‑cell lymphoproliferative disorder when...

Clinical insight

Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea

JAMA Dermatologyn=653
💡

In adults with moderate to severe papulopustular rosacea, 16 weeks of DFD-29 40 mg daily outperformed doxycycline 40 mg and placebo on IGA success...

Clinical insight

Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention

JAMA Dermatologyn=23
💡

For patients already on PD‑1/PD‑L1 therapy, AK burden and KC excisions may decline over 12 months. Do not start ICIs solely for field cancerization...

Clinical insight
Back to top